GSK China leadership change announcement
08 January 2019
Thomas Willemsen has successfully led GSK China as General Manager for two years. With a strengthened sales force and bolder ambition, GSK China is prepared to take the next step in its growth.
At the same time, GSK has an oncology pipeline which presents an opportunity for leaders with the necessary skills and knowledge. In turn, Thomas has accepted a new GSK leadership role of VP Oncology Strategy, Intercontinental and Emerging Markets.
Fabio Landazabal, SVP Emerging Markets, is moving with his family to Shanghai to assume direct responsibility for the GSK China Pharmaceuticals and Vaccines business on an interim basis while he and the company conducts an extensive global search for a new General Manager in China.